HIGHLIGHTS
- who: Tina Levstek and colleagues from the Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Vrazov trg, Ljubljana, Slovenia have published the research work: Biomarkers of Fabry Nephropathy: Review and Future Perspective, in the Journal: Genes 2020, 11, x FOR PEER REVIEW of /2020/
- what: The aim of this Article is to provide an overview of nephropathy in Fabry patients and the biomarkers currently used in the diagnosis and follow-up. Probably the main reason why cystatin-C is not widely used is that it is more costly, time-consuming, and less available than . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.